Bleeding complications in patients with out-of-hospital cardiac arrest treated with cangrelor and oral P2Y12 inhibitors
European Heart Journal: Acute Cardiovascular Care · 2025
DOI: 10.1093/ehjacc/zuaf082 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Heart Journal: Acute Cardiovascular Care, 2025. Verfasst von Georg Gelbenegger und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Out-of-Hospital Cardiac Arrest, Purinergic P2Y Receptor Antagonists, Percutaneous Coronary Intervention, Adenosine Monophosphate. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Reanimation
Abstract (Originalsprache)
Aims
Cangrelor is used to bridge the gap of insufficient platelet inhibition in patients with out-of-hospital cardiac arrest (OHCA) undergoing percutaneous coronary intervention (PCI). Methods and results In a retrospective chart review study, we investigated the incidence of bleeding and stent thrombosis in patients with OHCA undergoing PCI who received either cangrelor and transition to an oral P2Y12 inhibitor or an oral P2Y12 inhibitor alone. Subgroups consisted of patients treated with conventional cardiopulmonary resuscitation (CPR) and extracorporeal CPR. The primary endpoint was Bleeding Academic Research Consortium (BARC) 3–5 bleeding at 30 days. Between January 2016 and March 2025, 414 patients were included of which 267 received cangrelor and an oral P2Y12 inhibitor and 147 received an oral P2Y12 inhibitor alone. BARC 3–5 bleeding at 30 days occurred at a similar rate in the cangrelor group and the oral P2Y12 inhibitor group (18.4% vs. 19.0%, respectively; adjusted OR, 0.79; 95% CI, 0.45–1.39). BARC 3–5 bleeding at 6, 24 and 48 h was similar between the cangrelor group and the oral P2Y12 inhibitor group in patients treated with conventional and extracorporeal CPR. In patients treated with extracorporeal CPR, stent thrombosis occurred less frequently in the cangrelor group compared with the oral P2Y12 inhibitor group (2.1% vs. 4.5%, respectively; adjusted OR, 0.32, 95% CI, 0.03–3.14), but without reaching statistical significance.
Conclusion
In patients with OHCA undergoing PCI, BARC 3–5 bleeding occurred at a similar rate in patients receiving either cangrelor and transition to an oral P2Y12 inhibitor or an oral P2Y12 inhibitor alone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
- Department of Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria.
- Department of Medicine I, Medical University of Vienna, Vienna, Austria.
- Department of Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria.
- Department of Emergency Medicine, Medical University of Vienna, Vienna, Austria.
- Department of Medicine III, Division of Cardiology, Medical University of Innsbruck, Innsbruck, Austria.
ORCID-Profile: Georg Gelbenegger, Robert Zilberszac, Thomas Staudinger, Guy Friedrich, Irene M Lang, Jolanta M Siller-Matula
Zitieren
APA
Gelbenegger, G., Lipa, A. J., Jorda, A., Zilberszac, R., Heinz, G., Staudinger, T., Zauner, C., Holzer, M., Friedrich, G., Plank, F., Lang, I. M., Jilma, B., & Siller-Matula, J. M. (2025). Bleeding complications in patients with out-of-hospital cardiac arrest treated with cangrelor and oral P2Y12 inhibitors. European Heart Journal: Acute Cardiovascular Care. https://doi.org/10.1093/ehjacc/zuaf082
Vancouver
Gelbenegger G, Lipa AJ, Jorda A, Zilberszac R, Heinz G, Staudinger T, et al. Bleeding complications in patients with out-of-hospital cardiac arrest treated with cangrelor and oral P2Y12 inhibitors. European Heart Journal: Acute Cardiovascular Care. 2025. doi:10.1093/ehjacc/zuaf082
BibTeX
@article{Gelbenegger2025,
author = {Gelbenegger, Georg and Lipa, Alexandra Julia and Jorda, Anselm and Zilberszac, Robert and Heinz, Gottfried and Staudinger, Thomas and Zauner, Christian and Holzer, Michael and Friedrich, Guy and Plank, Fabian and Lang, Irene M and Jilma, Bernd and Siller-Matula, Jolanta M},
title = {Bleeding complications in patients with out-of-hospital cardiac arrest treated with cangrelor and oral P2Y12 inhibitors},
journal = {European Heart Journal: Acute Cardiovascular Care},
year = {2025},
doi = {10.1093/ehjacc/zuaf082}
}
EUVIMED